Literature DB >> 7926454

Immunization of BALB/c mice against Helicobacter felis infection with Helicobacter pylori urease.

P Michetti1, I Corthésy-Theulaz, C Davin, R Haas, A C Vaney, M Heitz, J Bille, J P Kraehenbuhl, E Saraga, A L Blum.   

Abstract

BACKGROUND/AIMS: Because Helicobacter pylori is a potentially dangerous human pathogen, the protective potential of oral immunization with H. pylori urease and its subunits was evaluated in an animal model.
METHODS: Mice were orally immunized with H. pylori sonicate, urease, or recombinant enzymatically inactive urease subunits and then challenged with Helicobacter felis. Control mice were sham-immunized.
RESULTS: H. felis colonization was present 5 days after challenge in 9 of 10 sham-immunized, 6 of 9 sonicate-immunized, and 3 of 10 urease-immunized animals (P = 0.031 vs. sham-immunized). Twelve days after challenge, urease B-immunized mice had a weaker colonization than sham-immunized controls, whereas urease A had no effect. After 70 days, most urease A- and urease B-immunized mice had cleared the colonization (10/17: P = 0.0019; 16/20: P = 0.00002 vs. sham-immunized). In urease B-immunized animals, protection was often associated with corpus gastritis.
CONCLUSIONS: Oral immunization with H. pylori urease protects mice against H. felis infection. Enzymatically inactive urease A and B subunits contain protective epitopes. It is unclear whether protection depends on the development of a mononuclear inflammatory response in the gastric corpus. Our observations should encourage the development of a human vaccine.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7926454     DOI: 10.1016/0016-5085(94)90224-0

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  67 in total

Review 1.  Naturally acquired human immune responses against Helicobacter pylori and implications for vaccine development.

Authors:  Y Zevering; L Jacob; T F Meyer
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

2.  Local secretory immunoglobulin A and postimmunization gastritis correlate with protection against Helicobacter pylori infection after oral vaccination of mice.

Authors:  T Goto; A Nishizono; T Fujioka; J Ikewaki; K Mifune; M Nasu
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

3.  Protective efficacy of recombinant urease B and aluminum hydroxide against Helicobacter pylori infection in a mouse model.

Authors:  Rodolfo E Bégué; Halina Sadowska-Krowicka
Journal:  FEMS Immunol Med Microbiol       Date:  2010-08-23

4.  The urease enzyme of Helicobacter pylori does not function as an adhesin.

Authors:  M Clyne; B Drumm
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

5.  Differential stimulation of interleukin-12 (IL-12) and IL-10 by live and killed Helicobacter pylori in vitro and association of IL-12 production with gamma interferon-producing T cells in the human gastric mucosa.

Authors:  H A Haeberle; M Kubin; K B Bamford; R Garofalo; D Y Graham; F El-Zaatari; R Karttunen; S E Crowe; V E Reyes; P B Ernst
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

6.  Murine splenocytes induce severe gastritis and delayed-type hypersensitivity and suppress bacterial colonization in Helicobacter pylori-infected SCID mice.

Authors:  K A Eaton; S R Ringler; S J Danon
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

7.  Analysis of immunoglobulin A antibodies to Helicobacter pylori in serum and gastric juice in relation to mucosal inflammation.

Authors:  S Hayashi; T Sugiyama; K Yokota; H Isogai; E Isogai; K Oguma; M Asaka; N Fujii; Y Hirai
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

8.  Surface localization of Helicobacter pylori urease and a heat shock protein homolog requires bacterial autolysis.

Authors:  S H Phadnis; M H Parlow; M Levy; D Ilver; C M Caulkins; J B Connors; B E Dunn
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

9.  Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB.

Authors:  M H Coconnier; V Lievin; E Hemery; A L Servin
Journal:  Appl Environ Microbiol       Date:  1998-11       Impact factor: 4.792

10.  Recombinant cholera toxin B subunit is not an effective mucosal adjuvant for oral immunization of mice against Helicobacter felis.

Authors:  T G Blanchard; N Lycke; S J Czinn; J G Nedrud
Journal:  Immunology       Date:  1998-05       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.